 LOS ALTOS, Calif., Sept. 15, 2021 PRNewswire -- Unicycive Therapeutics, Inc. Nasdaq: UNCY, a clinical stage biotechnology company developing therapies for patients with kidney disease, today announced the Company is scheduled to be added as a member of the Russell Microcap Index as part of the 2021 Russell indexes reconstitution after the market opens on September 20, 2021, based on a preliminary list of additions. 